LRI Investments LLC Buys 23,169 Shares of IQVIA Holdings Inc. (NYSE:IQV)

LRI Investments LLC raised its stake in IQVIA Holdings Inc. (NYSE:IQV) by 3,542.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 23,823 shares of the medical research company’s stock after buying an additional 23,169 shares during the period. IQVIA comprises about 0.5% of LRI Investments LLC’s portfolio, making the stock its 28th biggest position. LRI Investments LLC’s holdings in IQVIA were worth $5,645,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. First Foundation Advisors raised its stake in IQVIA by 3.8% in the 2nd quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock valued at $245,000 after acquiring an additional 43 shares during the period. Invera Wealth Advisors LLC boosted its holdings in IQVIA by 0.3% in the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock worth $3,183,000 after buying an additional 46 shares during the period. Private Trust Co. NA grew its stake in IQVIA by 10.7% in the 3rd quarter. Private Trust Co. NA now owns 485 shares of the medical research company’s stock valued at $115,000 after buying an additional 47 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in shares of IQVIA by 0.3% during the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock worth $3,313,000 after acquiring an additional 48 shares in the last quarter. Finally, Continuum Advisory LLC boosted its holdings in shares of IQVIA by 3.3% in the second quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company’s stock worth $325,000 after acquiring an additional 49 shares during the period. 89.62% of the stock is currently owned by institutional investors.

IQVIA Stock Up 1.4 %

IQV opened at $202.63 on Monday. IQVIA Holdings Inc. has a 12 month low of $187.62 and a 12 month high of $261.73. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The business’s 50-day moving average price is $215.18 and its 200-day moving average price is $225.10. The company has a market cap of $36.78 billion, a P/E ratio of 26.59, a P/E/G ratio of 2.08 and a beta of 1.49.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on IQV shares. Robert W. Baird dropped their price objective on IQVIA from $256.00 to $223.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. JPMorgan Chase & Co. reduced their price objective on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a research note on Tuesday, November 5th. Truist Financial lowered their target price on shares of IQVIA from $286.00 to $265.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Finally, Barclays dropped their price objective on IQVIA from $260.00 to $255.00 and set an “overweight” rating for the company in a research note on Friday, November 1st. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $256.50.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.